Treatment offers hope to CF sufferers

A major treatment breakthrough offers new hope for cystic fibrosis sufferers.

A combination therapy, developed by US pharmaceutical company, Vertex, improves lung function and reduces hospitalisations for patients with the most common type of CF.

In particular, it reduced lung infections by between 30 and 39% and helped people with CF to gain weight.